Skip to content
Open access

Lutein Attenuates Lipid Accumulation in Association with TFEB Nuclear Translocation and Autophagy–Lysosomal Responses in a Cellular Model of Hepatic Steatosis

Aug 2026 · Antioxidants · Vol 15, pp. 1042 · 0 citations · 31 references
Medicine

TL;DR

Findings position the antioxidant lutein as a candidate natural compound whose lipid-lowering action is associated with TFEB nuclear translocation/activation and with the autophagy–lysosomal pathway, warranting further investigation in MASLD.

Abstract

Lutein is a dietary xanthophyll carotenoid valued for its antioxidant properties that has been shown to benefit liver health and reduce hepatic lipid accumulation; however, this lipid-lowering effect cannot be fully attributed to its antioxidant activity, and the underlying mechanism remains poorly understood. Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive hepatic lipid accumulation, oxidative stress, and limited therapeutic options. Transcription factor EB (TFEB) coordinates the autophagy–lysosomal pathways involved in cellular lipid clearance, including lipophagy and lysosomal exocytosis, and is sensitive to the cellular redox state; however, whether the antioxidant lutein modulates TFEB-regulated lipid homeostasis remains unclear. HepG2 cells were exposed to free fatty acids (FFAs) to induce intracellular lipid accumulation and co-treated with lutein. TFEB localization and the expression of TFEB-related genes were assessed by immunofluorescence and qPCR, respectively. Immunofluorescence was also used to evaluate lipid droplet accumulation, LC3 content, and LAMP1 localization. Lipid droplet ultrastructure was analyzed by transmission electron microscopy, and extracellular triglyceride levels were measured as a functional readout of lipid extrusion. Lutein attenuated lipid droplet accumulation in FFA-treated cells, increased nuclear TFEB immunoreactivity, upregulated LC3 mRNA expression, and enhanced LC3 colocalization with lipid droplets. Chloroquine abolished the lipid-lowering effect of lutein, supporting an autophagy-dependent mechanism. In addition, lutein increased the abundance of LAMP1-positive compartments, while ultrastructural analysis and elevated extracellular triglyceride levels suggested enhanced lipid extrusion. These findings position the antioxidant lutein as a candidate natural compound whose lipid-lowering action is associated with TFEB nuclear translocation/activation and with the autophagy–lysosomal pathway, warranting further investigation in MASLD.

Read PDF

Similar papers

Oct 2026

BTRC aggravates FFA-induced lipid accumulation in MASLD via G3BP1 degradation and subsequent SIRT6 mRNA destabilization.

BACKGROUND Metabolic dysfunction associated steatotic liver disease (MASLD) features hepatic steatosis and lipotoxicity, yet its molecular mechanisms remain incompletely understood. How post-transcriptional regulation and protein turnover shape hepatocyte lipid homeostasis in MASLD requires further elucidation. METHO...

Dong-Mei Zou, Liang Liu, Cheng-Yang Yang et al. · 0 citations
Sep 2026

Liraglutide Attenuates Hepatocyte Ferroptosis in an In Vitro Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Liraglutide demonstrated the ability to mitigate lipid accumulation, oxidative stress, and iron overload in HepG2 cells subjected to FFA-induced injury, suggesting a mechanistic basis for the potential protective role of liraglutide in MASLD.

J. Bai, Y. Xiao, P. Lou et al. · 0 citations
Sep 2026

Sinusoidal endothelial cells orchestrate liver inflammation and lipid metabolism via USP12/CD36 axis being the target of celastrol therapy.

Disordered lipid metabolism and inflammation, the hallmark features of metabolic dysfunction-associated steatohepatitis (MASH), present a significant therapeutic challenge even in the absence of obesity, making the discovery of novel pathogenic mechanisms and therapies imperative. Although Celastrol (Cel) markedly amel...

Hu Hua, Wen-Ping Zhu, Le-Hang Sun et al. · 0 citations
Open access Aug 2026

Effects of Bound Polyphenols on Lipid Metabolism in HepG2 Cells and Glucose-Induced C. elegans Models

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disease associated with insulin resistance and hepatic lipid accumulation. Polyphenols have attracted considerable attention for their hepatoprotective and lipid-lowering activities. Our previous studies characterized a bound p...

Israr Ghani, Qin-Qin Qiao, Song-Tao Li et al. · 0 citations
Open access Sep 2026

Integrin beta-like 1 protects against liver injury by inhibiting ferroptosis in metabolic dysfunction-associated steatohepatitis.

BACKGROUND AND AIMS Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by hepatic lipid accumulation, inflammation, and oxidative injury. However, the regulatory role of integrin beta-like 1 (ITGBL1) in MASH remains unknown. METHODS ITGBL1 knockout (KO) and liver-specific overexpressing mice wer...

Wen-Zhuo Dai, Qi-Qi Ren, Hong Gu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.